Point estimates are predicted values from 22 industry-specific OLS regressions of industry-specific share of non-performing loans on historical exposure to real estate development, the growth between 2005Q1 and 2008Q4 of provincial house prices, region dummies and a dummy for savings banks.
Increases in annual NPP in excess of 40% of the 1990 estimates are predicted for the Brigalow Belt North, Carnarvon, Central Highlands, Cobar Peneplain, Darling Riverine Plain, and Riverina biogeographic regions (see Table 1), with the latter, a major cereal production region, exceeding 50% by the year 2100.
Appreciation Factor data from 34 North Sea fields is used to calibrate and validate the model showing that the evolution of EUR estimates is predicted with 82.4% of validation data points within the simulated P10 and P90 uncertainty envelope, which should theoretically cover 80% of data points if there is no model error.
The FEDIOL model produced average estimates of PUFA that were slightly lower than estimates from the literature, which is to be expected because the FEDIOL model is predicting PUFA intake from vegetable oils and fats only whereas the literature estimates are predicting PUFA intakes from all sources.
Type 2 diabetes mellitus (T2DM) is a challenging global public health problem. 1 In 2007 there was an estimated 144 000 adults with diabetes in Ireland, and by 2020 the total estimate is predicted to raise to over 233 000. 2 Across Europe, T2DM accounts for over 85%90%% of all diabetes cases.
Mean adjusted estimates for the five populations were predicted and displayed graphically.
Individual-level estimates of residential BC concentrations were predicted from a validated spatiotemporal land-use regression model.
Finally simple formulae were predicted to estimate the different scour and deposition parameters.
As per WHO estimates, RTI, are predicted to be the fifth leading cause of death in all age groups by the year 2030.
Using the AHEAD model to extend independently published short-term efficacy estimates, galantamine is predicted to lead to a somewhat longer delay of the need for FTC and ultimately lower costs, thus dominating other treatment options.
